Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.
Grommes C, Tang SS, Wolfe J, Kaley TJ, Daras M, Pentsova EI, Piotrowski AF, Stone J, Lin A, Nolan CP, Manne M, Codega P, Campos C, Viale A, Thomas AA, Berger MF, Hatzoglou V, Reiner AS, Panageas KS, DeAngelis LM, Mellinghoff IK. Grommes C, et al. Among authors: hatzoglou v. Blood. 2019 Jan 31;133(5):436-445. doi: 10.1182/blood-2018-09-875732. Epub 2018 Dec 19. Blood. 2019. PMID: 30567753 Free PMC article. Clinical Trial.
Post-treatment T1 shortening in primary CNS lymphoma.
Karimi S, Hatzoglou V, Punia V, Partovi S, Abrey LE, Deangelis LM. Karimi S, et al. Among authors: hatzoglou v. J Neurooncol. 2013 Jan;111(1):25-31. doi: 10.1007/s11060-012-0984-3. Epub 2012 Oct 17. J Neurooncol. 2013. PMID: 23073601
Temporal lobe meningioma with ipsilateral herpes simplex encephalitis.
Diamond EL, Hatzoglou V, Santomasso B, Rosenblum M, Pentsova E. Diamond EL, et al. Among authors: hatzoglou v. Neurohospitalist. 2014 Jan;4(1):42-3. doi: 10.1177/1941874413489154. Neurohospitalist. 2014. PMID: 24381710 Free PMC article. No abstract available.
Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.
Lin X, Lee M, Buck O, Woo KM, Zhang Z, Hatzoglou V, Omuro A, Arevalo-Perez J, Thomas AA, Huse J, Peck K, Holodny AI, Young RJ. Lin X, et al. Among authors: hatzoglou v. AJNR Am J Neuroradiol. 2017 Mar;38(3):485-491. doi: 10.3174/ajnr.A5023. Epub 2016 Dec 8. AJNR Am J Neuroradiol. 2017. PMID: 27932505 Free PMC article.
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Grommes C, Pastore A, Palaskas N, Tang SS, Campos C, Schartz D, Codega P, Nichol D, Clark O, Hsieh WY, Rohle D, Rosenblum M, Viale A, Tabar VS, Brennan CW, Gavrilovic IT, Kaley TJ, Nolan CP, Omuro A, Pentsova E, Thomas AA, Tsyvkin E, Noy A, Palomba ML, Hamlin P, Sauter CS, Moskowitz CH, Wolfe J, Dogan A, Won M, Glass J, Peak S, Lallana EC, Hatzoglou V, Reiner AS, Gutin PH, Huse JT, Panageas KS, Graeber TG, Schultz N, DeAngelis LM, Mellinghoff IK. Grommes C, et al. Among authors: hatzoglou v. Cancer Discov. 2017 Sep;7(9):1018-1029. doi: 10.1158/2159-8290.CD-17-0613. Epub 2017 Jun 15. Cancer Discov. 2017. PMID: 28619981 Free PMC article. Clinical Trial.
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.
Bhatia A, Hatzoglou V, Ulaner G, Rampal R, Hyman DM, Abdel-Wahab O, Durham BH, Dogan A, Ozkaya N, Yabe M, Petrova-Drus K, Panageas KS, Reiner A, Rosenblum M, Diamond EL. Bhatia A, et al. Among authors: hatzoglou v. Neuro Oncol. 2020 Jul 7;22(7):979-992. doi: 10.1093/neuonc/noaa008. Neuro Oncol. 2020. PMID: 31950179 Free PMC article.
18F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study.
Kirchner J, Hatzoglou V, Buthorn JB, Bossert D, Sigler AM, Reiner AS, Ulaner GA, Diamond EL. Kirchner J, et al. Among authors: hatzoglou v. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1154-1165. doi: 10.1007/s00259-020-05047-8. Epub 2020 Oct 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33057928 Free PMC article.
67 results